These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33103428)

  • 1. Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and
    Horatscheck A; Andrijevic A; Nchinda AT; Le Manach C; Paquet T; Khonde LP; Dam J; Pawar K; Taylor D; Lawrence N; Brunschwig C; Gibhard L; Njoroge M; Reader J; van der Watt M; Wicht K; de Sousa ACC; Okombo J; Maepa K; Egan TJ; Birkholtz LM; Basarab GS; Wittlin S; Fish PV; Street LJ; Duffy J; Chibale K
    J Med Chem; 2020 Nov; 63(21):13013-13030. PubMed ID: 33103428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ
    Nchinda AT; Le Manach C; Paquet T; Gonzàlez Cabrera D; Wicht KJ; Brunschwig C; Njoroge M; Abay E; Taylor D; Lawrence N; Wittlin S; Jiménez-Díaz MB; Santos Martínez M; Ferrer S; Angulo-Barturen I; Lafuente-Monasterio MJ; Duffy J; Burrows J; Street LJ; Chibale K
    J Med Chem; 2018 May; 61(9):4213-4227. PubMed ID: 29665687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.
    Le Manach C; Nchinda AT; Paquet T; Gonzàlez Cabrera D; Younis Y; Han Z; Bashyam S; Zabiulla M; Taylor D; Lawrence N; White KL; Charman SA; Waterson D; Witty MJ; Wittlin S; Botha ME; Nondaba SH; Reader J; Birkholtz LM; Jiménez-Díaz MB; Martínez MS; Ferrer S; Angulo-Barturen I; Meister S; Antonova-Koch Y; Winzeler EA; Street LJ; Chibale K
    J Med Chem; 2016 Nov; 59(21):9890-9905. PubMed ID: 27748596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationship Studies and Plasmodium Life Cycle Profiling Identifies Pan-Active N-Aryl-3-trifluoromethyl Pyrido[1,2- a]benzimidazoles Which Are Efficacious in an in Vivo Mouse Model of Malaria.
    Mayoka G; Njoroge M; Okombo J; Gibhard L; Sanches-Vaz M; Fontinha D; Birkholtz LM; Reader J; van der Watt M; Coetzer TL; Lauterbach S; Churchyard A; Bezuidenhout B; Egan TJ; Yeates C; Wittlin S; Prudêncio M; Chibale K
    J Med Chem; 2019 Jan; 62(2):1022-1035. PubMed ID: 30562027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial Benzimidazole Derivatives Incorporating Phenolic Mannich Base Side Chains Inhibit Microtubule and Hemozoin Formation: Structure-Activity Relationship and
    Dziwornu GA; Coertzen D; Leshabane M; Korkor CM; Cloete CK; Njoroge M; Gibhard L; Lawrence N; Reader J; van der Watt M; Wittlin S; Birkholtz LM; Chibale K
    J Med Chem; 2021 Apr; 64(8):5198-5215. PubMed ID: 33844521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of Malaria.
    Kandepedu N; Gonzàlez Cabrera D; Eedubilli S; Taylor D; Brunschwig C; Gibhard L; Njoroge M; Lawrence N; Paquet T; Eyermann CJ; Spangenberg T; Basarab GS; Street LJ; Chibale K
    J Med Chem; 2018 Jul; 61(13):5692-5703. PubMed ID: 29889526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite Strains.
    Le Manach C; Paquet T; Wicht K; Nchinda AT; Brunschwig C; Njoroge M; Gibhard L; Taylor D; Lawrence N; Wittlin S; Eyermann CJ; Basarab GS; Duffy J; Fish PV; Street LJ; Chibale K
    J Med Chem; 2018 Oct; 61(20):9371-9385. PubMed ID: 30256636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
    Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
    J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of Action.
    Kumar M; Okombo J; Mambwe D; Taylor D; Lawrence N; Reader J; van der Watt M; Fontinha D; Sanches-Vaz M; Bezuidenhout BC; Lauterbach SB; Liebenberg D; Birkholtz LM; Coetzer TL; Prudêncio M; Egan TJ; Wittlin S; Chibale K
    ACS Infect Dis; 2019 Feb; 5(2):303-315. PubMed ID: 30525439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of
    Dziwornu GA; Seanego D; Fienberg S; Clements M; Ferreira J; Sypu VS; Samanta S; Bhana AD; Korkor CM; Garnie LF; Teixeira N; Wicht KJ; Taylor D; Olckers R; Njoroge M; Gibhard L; Salomane N; Wittlin S; Mahato R; Chakraborty A; Sevilleno N; Coyle R; Lee MCS; Godoy LC; Pasaje CF; Niles JC; Reader J; van der Watt M; Birkholtz LM; Bolscher JM; de Bruijni MHC; Coulson LB; Basarab GS; Ghorpade SR; Chibale K
    J Med Chem; 2024 Jul; 67(13):11401-11420. PubMed ID: 38918002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
    Vijayaraghavan S; Mahajan S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
    Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.
    Vanaerschot M; Murithi JM; Pasaje CFA; Ghidelli-Disse S; Dwomoh L; Bird M; Spottiswoode N; Mittal N; Arendse LB; Owen ES; Wicht KJ; Siciliano G; Bösche M; Yeo T; Kumar TRS; Mok S; Carpenter EF; Giddins MJ; Sanz O; Ottilie S; Alano P; Chibale K; Llinás M; Uhlemann AC; Delves M; Tobin AB; Doerig C; Winzeler EA; Lee MCS; Niles JC; Fidock DA
    Cell Chem Biol; 2020 Jul; 27(7):806-816.e8. PubMed ID: 32359426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
    Le Manach C; Paquet T; Brunschwig C; Njoroge M; Han Z; Gonzàlez Cabrera D; Bashyam S; Dhinakaran R; Taylor D; Reader J; Botha M; Churchyard A; Lauterbach S; Coetzer TL; Birkholtz LM; Meister S; Winzeler EA; Waterson D; Witty MJ; Wittlin S; Jiménez-Díaz MB; Santos Martínez M; Ferrer S; Angulo-Barturen I; Street LJ; Chibale K
    J Med Chem; 2015 Nov; 58(21):8713-22. PubMed ID: 26502160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).
    Chapman TM; Osborne SA; Bouloc N; Large JM; Wallace C; Birchall K; Ansell KH; Jones HM; Taylor D; Clough B; Green JL; Holder AA
    Bioorg Med Chem Lett; 2013 May; 23(10):3064-9. PubMed ID: 23570789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an Atg8-Atg3 protein-protein interaction inhibitor from the medicines for Malaria Venture Malaria Box active in blood and liver stage Plasmodium falciparum parasites.
    Hain AU; Bartee D; Sanders NG; Miller AS; Sullivan DJ; Levitskaya J; Meyers CF; Bosch J
    J Med Chem; 2014 Jun; 57(11):4521-31. PubMed ID: 24786226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibitors of malarial P. Falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines.
    Large JM; Birchall K; Bouloc NS; Merritt AT; Smiljanic-Hurley E; Tsagris DJ; Wheldon MC; Ansell KH; Coombs PJ; Kettleborough CA; Whalley D; Stewart LB; Bowyer PW; Baker DA; Osborne SA
    Bioorg Med Chem Lett; 2019 Feb; 29(3):509-514. PubMed ID: 30553738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial benzoheterocyclic 4-aminoquinolines: Structure-activity relationship, in vivo evaluation, mechanistic and bioactivation studies.
    Ongarora DS; Strydom N; Wicht K; Njoroge M; Wiesner L; Egan TJ; Wittlin S; Jurva U; Masimirembwa CM; Chibale K
    Bioorg Med Chem; 2015 Sep; 23(17):5419-32. PubMed ID: 26264839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice.
    Joshi MC; Okombo J; Nsumiwa S; Ndove J; Taylor D; Wiesner L; Hunter R; Chibale K; Egan TJ
    J Med Chem; 2017 Dec; 60(24):10245-10256. PubMed ID: 29185748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.